Follow
Genomic Testing
Genomic Testing is designed to help identify DNA alterations and is done on cancerous tissue in order to provide information with it. It evaluates the genes in a sample of diseased tissue from a cancer patient.
APR 11, 2023 | 11:00 AM
Date: April 11, 2023 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Antimicrobial resistant (AMR) infections are on the rise causing approximately 1.3M deaths each year due to patients suc...
MAR 30, 2023 | 1:50 PM
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
MAR 30, 2023 | 1:50 PM
Liquid biopsy tests are an integral part of the molecular diagnostic workup of cancer specimens. We have performed extensive validation studies of the GeneStrat NGS test (GSNGS), that uses a...
MAR 30, 2023 | 12:05 PM
Dr. Ritterhouse's laboratory has implemented rapid and ultra rapid protocol for NSCLC genomic profiling, based on NGS. This has led to significant shortening of turn around time (TAT) an...
MAR 30, 2023 | 5:10 PM
This talk will highlight key changes to the various guidelines in myeloid and lymphoid testing, commenting on the current and future landscape of biomarkers. The speakers will then share the...
MAR 30, 2023 | 4:45 PM
Prof. Hofman will present results of a multi-centric study evaluating performance of new Oncomine Dx Express Test, CE IVD for genomic profiling of cancer patient samples. The data cover perf...
MAR 30, 2023 | 3:15 PM
In her presentation Prof. Staebler will share data generated by new Genomic Assessment Metrics (GIM) software for HRD assessment, and Oncomine Comprehensive Assay Plus. The samples tested we...
MAR 30, 2023 | 1:50 PM
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms...
